2 results
Approved WMORecruiting
To attenuate the impact and duration of delayed graft funtion by dampening schemia reperfusion injury
Approved WMORecruiting
The main objectives Investigate a first signal of efficacy, safety and tolerability of BI 706321 in combination with ustekinumab treatment compared to placebo with ustekinumab treatment in patients with moderately to severely active CD at 12 weeks.…